ORTHO-CLINICAL DIAGNOSTICS
ActiveKey figures
† ORTHO-CLINICAL DIAGNOSTICS filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.
Ratios
2025Sector comparison
SIC 21100Where the company stands among the 1,055 active companies whose first SIC code is 21100 (Manufacture of basic pharmaceutical products).
- GE HEALTHCARE LIMITED£5.6bn
- THERMO FISHER SCIENTIFIC LIFE HOLDINGS LIMITED£1.4bn
- LRC PRODUCTS LIMITED£1bn
- SMITHKLINE BEECHAM LIMITED£940m
- DECHRA LIMITED£780.1m
- IPSEN BIOPHARM LIMITED£588.2m
- ORTHO-CLINICAL DIAGNOSTICS£295.7m
- BESPAK EUROPE LIMITED£256m
- SEQIRUS VACCINES LIMITED£254.2m
- IOVANCE BIOTHERAPEUTICS UK LTD£199.7m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 1,055. The line on each bar marks the median.
Summary: ORTHO-CLINICAL DIAGNOSTICS
What kind of company is it?
ORTHO-CLINICAL DIAGNOSTICS is a private unlimited company registered with Companies House under company number 02549777. It was incorporated on 18 Oct 1990. Its status is active. The registered office is in Bridgend (CF35). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100).
How is the company doing financially?
The latest accounts in the database are for 2025 (period ending 28 Dec 2025); the company files full accounts. Turnover was £307,114,000. Profit for the year was £35,917,000. Net assets were £295,689,000, up 7.5% on the previous year. Cash at bank and in hand was £3,135,000. Total assets were £419,582,000 and total liabilities £107,509,000. Figures are available for 2 financial years (2024–2025).
How does it compare with similar companies?
Compared with 1,055 active companies whose first SIC code is 21100: By turnover it ranks higher than 94% of the 97 that publish turnover (median £23,360,137). By net assets it ranks higher than 97% of them (median £41,497). By total assets it ranks higher than 97% of them (median £308,978). By cash it ranks higher than 87% of them (median £135,555). It is older than 89% of them (median age 9.0 years).
Does it supply the public sector?
The company is named as a supplier in 12 public contract award notices from 11 public sector buyers since 2015. Contracts awarded to it alone have a combined published value of £725.7m. Its most frequent buyer is NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University… (2 contracts). 3 of the awards are shared with other suppliers, typically framework agreements. It is recorded as the recipient of 3 central government grants worth £9.1m, mainly from Department for Science, Innovation and Technology.
What do public registers and reports show?
It appears on the Home Office register of licensed sponsors (Global Business Mobility: Senior or Specialist Worker, Skilled Worker). HMRC lists it as an importer of goods, mainly pharmaceuticals, miscellaneous chemicals, plastics. HMRC lists it as an exporter of goods, mainly pharmaceuticals, miscellaneous chemicals, plastics. In its latest payment practices report it took an average of 41 days to pay suppliers, and 28% of invoices were not paid within agreed terms. Its gender pay gap report for 2025/26 shows median hourly pay for women 2.3% lower than for men. It has a modern slavery statement on the government registry.
Who runs and controls the company?
One person with significant control is registered.
When are its next filings due?
The next confirmation statement is due by 9 Oct 2027.
Filed accounts2024–2025
| 2024 † | 2025 † | |
|---|---|---|
| Turnover | 315,978,000 | 307,114,000 |
| Profit for the year | 72,238,000 | 35,917,000 |
| Cash at bank and in hand | 957,000 | 3,135,000 |
| Total assets | 357,608,000 | 419,582,000 |
| Total liabilities | 69,085,000 | 107,509,000 |
| Net assets / total equity | 274,949,000 | 295,689,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Public contracts
12 contractsORTHO-CLINICAL DIAGNOSTICS is named as a supplier in 12 public contract award notices from 11 public sector buyers since 2015. The 9 contracts awarded to it alone with a published value add up to £725.7m. 3 awards are shared with other suppliers and not counted in that total.
- NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University…
- 2 contracts · £3.6m
- NHS Shared Business Services Limited
- 1 contract · £652.5m
- The Royal Wolverhampton NHS Trust
- 1 contract · £50m
- Department of Health and Social Care (DHSC)
- 1 contract · £9.5m
- NHS Wales Shared Services Partnership
- 1 contract · £3.8m
- UKHSA Diagnostics & Research Open Framework‡Secretary of State for Health and Social Care acting as part of the Crown through UK Heal… · shared by 81 suppliers, up to £5,200,000,000 in total · runs until Sep 2028
- T.0340 Blood Transfusion Automation Managed Service Contract for Betsi Cadwaladr University Health BoardBetsi Cadwaladr University Health Board · £3,608,242 · runs until Nov 2027
- CLINICAL MANAGED SERVICES, INCLUDING MANAGED MAINTENANCE SERVICES (SBS10251)NHS Shared Business Services Limited · £652,500,000
- Maintenance of maldi biotyper mass spectrometer‡NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University… · shared by 47 suppliers, up to £15,400,000,001 in total · 4 lots
- Pathology Managed Services Framework‡The Royal Wolverhampton NHS Trust · £50,000,000
Show 7 more
- Blood Transfusion Reagent Rental‡University Hospitals of Coventry and Warwickshire NHS Trust (“UHCW”) · £200,000
- National Microbiology Framework - Lot 1: Diagnostic Goods and Services‡Public Health England · shared by 100 suppliers, up to £3,000,000,000 in total
- Covid-19 Testing Pillar 3 - Serology (Anti-body) Tests contract, Ortho Clinical‡Department of Health and Social Care (DHSC) · £9,482,140 · 2 lots
- COVID-19 Reagant Agreement for Anti-body Testing‡NHS Wales Shared Services Partnership · £3,800,000
- Automated Blood Transfusion System Managed ServiceHull & East Yorkshire Hospitals Nhs Trust · £504,884
- T.0340 Blood Transfusion Automation Managed Service Contract for Betsi Cadwaladr University Health Board‡NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University… · £3,608,242
- Automated Blood Group Analyser‡THE PENNINE ACUTE HOSPITAL N H S TRUST · £1,957,034
From contract award notices on Contracts Finder (since 2016) and Find a Tender (since 2021), published by the Cabinet Office under the Open Government Licence v3.0. Values are as published by the buyer and usually cover the whole contract term; the total leaves out awards shared between several suppliers, where the published figure is a ceiling for all of them, placeholder values and single figures of £1 billion or more. Notices marked ‡ do not state a company number and were linked by an exact match on the registered name. Contracts below the publication thresholds and those of devolved buyers that publish elsewhere are not included.
Government grants
3 grantsORTHO-CLINICAL DIAGNOSTICS is recorded as the recipient of 3 central government grants since 2021, together worth £9.1m.
- Department for Science, Innovation and Technology
- 1 grant · £4.9m
- Department for Business, Energy and Industrial Strategy
- 2 grants · £4.2m
- LSIMFDepartment for Science, Innovation and Technology · £4,900,000 · Life Sciences Innovation Manufacturing Fund ('LSIMF')
- MDMTFDepartment for Business, Energy and Industrial Strategy · £2,109,200 · Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF)
- MDMTFDepartment for Business, Energy and Industrial Strategy · £2,109,200 · Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF)
From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.
Statutory reporting
- Average time taken to pay invoices
- 41 days
- Invoices not paid within agreed terms
- 28%
- Member of a payment code
- No
- Within 30 days 33%
- 31 to 60 days 57%
- After 60 days 10%
Earlier periods (7)
- Period ending
- Days to pay
- Within 30 days
- Late
- 31 Dec 2025
- 45
- 33%
- 24%
- 30 Jun 2025
- 42
- 37%
- 15%
- 31 Dec 2024
- 42
- 33%
- 26%
- 30 Jun 2024
- 43
- 35%
- 23%
- 31 Dec 2023
- 43
- 32%
- 22%
- 30 Jun 2023
- 53
- 30%
- 17%
- 31 Dec 2022
- 46
- 30%
- 19%
- Median hourly pay
- women 2.3% lower
- Mean hourly pay
- women 5.1% lower
- Median bonus pay
- women 20% higher
- Employer size
- 500 to 999 employees
Earlier years (8)
- Year
- Median hourly pay
- Mean hourly pay
- 2024/25
- women 4.8% lower
- women 5.3% lower
- 2023/24
- women 17% lower
- women 58% lower
- 2022/23
- women 8% higher
- women 2.9% lower
- 2021/22
- women 2.2% lower
- women 5.9% lower
- 2020/21
- women 3.5% lower
- women 4.8% lower
- 2019/20
- women 8.9% lower
- women 10% lower
- 2018/19
- women 10% lower
- women 11.5% lower
- 2017/18
- women 8.4% lower
- women 12.6% lower
A positive gap means women's average hourly pay is lower than men's across the whole employer; it is not a comparison of pay for the same work. View on the Gender pay gap service
- 2021
- Statement · summary on GOV.UK
Figures the company reported itself to the government's Check payment practices service, Gender pay gap service and Modern slavery statement registry (Open Government Licence v3.0). Only large companies and employers with 250 or more staff have to report, so most companies have nothing here.
Registers and licences
- Licence type and rating
- Worker (A rating)
- Routes
- Global Business Mobility: Senior or Specialist Worker, Skilled Worker
On the Home Office register of licensed sponsors, which lists organisations licensed to sponsor workers from overseas.
Listed by HMRC as an importer of goods in 12 of the last 12 months on record, most recently August 2026. Main goods: pharmaceuticals, miscellaneous chemicals, plastics, glass and machinery.
Listed by HMRC as an exporter of goods in 12 of the last 12 months on record, most recently August 2026. Main goods: pharmaceuticals, miscellaneous chemicals, plastics, machinery and glues and enzymes.
From HMRC's monthly lists of importers and exporters. Traders can ask to be left off the lists, so absence does not mean a company does not trade.
Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.
History
4 events- Financial year 2025 endedAccounts: turnover £307.1m, net assets £295.7m
- Financial year 2024 endedAccounts: turnover £316m, net assets £274.9m
- Crimson Ocd Uk Limited registered as a person with significant control
- Company incorporatedPrivate unlimited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.